The mRNA expression of ACE2 was related to some clinical parameters – age, AFP level and cirrhosis – of the HCC patients, it was also found to be associated with the prognoses of HCC patients, where the potential clinical value of ACE2 expression could be seen. The gene discussed is AFP; the disease is hepatocellular carcinoma.